China Shineway Pharmaceutical Group Ltd.  

(Public, HKG:2877)   Watch this stock  
Find more results for HKG: 2877
7.04
0.00 (0.00%)
Oct 20 - Close
HKG data delayed by 15 mins - Disclaimer
Currency in HKD
Range 7.04 - 7.13
52 week 6.82 - 9.86
Open 7.09
Vol / Avg. 1.28M/856,996.00
Mkt cap 5.82B
P/E 9.96
Div/yield 0.13/3.77
EPS 0.71
Shares 827.00M
Beta     -
Inst. own     -
Aug 29, 2017
Half Year 2017 China Shineway Pharmaceutical Group Ltd Earnings Presentation (Chinese)
Aug 29, 2017
Half Year 2017 China Shineway Pharmaceutical Group Ltd Earnings Release
Aug 3, 2017
Half Year 2017 China Shineway Pharmaceutical Group Ltd Profit Warning
  

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin 22.54% 29.56%
Operating margin 31.55% 34.88%
EBITD margin - 39.11%
Return on average assets 5.67% 9.34%
Return on average equity 6.48% 10.79%
Employees 3,628 -
CDP Score - -

Address

Luancheng
SHIJIAZHUANG, HEB 051430
China
+86-311-88030066 (Phone)
+86-311-88030088 (Fax)

Website links

Description

China Shineway Pharmaceutical Group Limited is an investment holding company principally engaged in the research and development, manufacture and trading of modern Chinese medicines. Its main products include injections, soft capsules and granules. The Company’s subsidiaries include Yuan Da International Limited, Hong Zhan International Limited and Shineway Pharmaceutical Sales Company Limited.

Officers and directors

Zhenjiang Li Executive Chairman of the Board, President
Age: 61
Bun Ching Lee Financial Controller, Company Secretary
Age: 44
Zhong Chen Executive Director
Age: 50
Ching Ton Lee Executive Director
Age: 34
Huimin Li Executive Director
Age: 49
Yunxia Xin Executive Director
Age: 53
Yat Hung Luk CPA Head - Investor Relation
Age: 58
Li Cheng Independent Non-Executive Director
Age: 57
Guoan Luo Independent Non-Executive Director
Age: 70
Liutai Sun Independent Non-Executive Director
Age: 53